Skip to content

A study highlighting network changes in patients with chronic insomnia accompanied by daytime sleepiness

A study highlighting network changes in patients with chronic insomnia accompanied by daytime sleepiness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097718
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

Chronic insomnia:No intervention
Good sleep control:No intervention

Sponsors

Chengdu Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Chronic insomnia with daytime sleepiness: (1) meet the CID diagnostic criteria outlined in the third edition of the International Classification of Sleep Disorders; (2) Pittsburgh Sleep Quality Index (PSQI) score >=7; (3) ESS score >=10; (4) Aged 18-60 years old; (5) HAMD score =26 points to exclude cognitive impairment; (6) Did not take any hypnotic drugs for 2 weeks before the neuropsychological test and MRI scan. Good sleep control group: (1) Pittsburgh Sleep Quality Index (PSQI) score < 7; (2) Objective neuropsychological tests were normal; (3) Age, sex and education level matched the control group.

Exclusion criteria

Exclusion criteria: Exclusion criteria for the control group with chronic insomnia and daytime sleepiness and good sleep: (1) a history of other neuropsychiatric disorders (such as the neurodegenerative disease Parkinson's disease) and serious chronic diseases (such as diabetes, heart disease, and cancer); (2) other sleep disorders, such as sleep-related breathing disorders (sleep apnea syndrome), central narcolepsy, circadian sleep-wake disorders, sleep-related movement disorders, and parasomnia; (3) Brain injury or high white matter signal detected by routine T2-weighted MRI scan; (4) History of addiction to drugs, alcohol, coffee, etc.; (5) There are contraindications for MRI.

Design outcomes

Secondary

MeasureTime frame
Emotion Related Scale;Cognitive scale;Blood test;

Primary

MeasureTime frame
insomnia related scale (PSQI and ISI and ESS);

Countries

China

Contacts

Public ContactLiang Gong

Chengdu Second People's Hospital

suegongliang@hotmail.com+86 173 6025 1891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026